GRO Biosciences
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
Insights
Recent Funding GRO Biosciences secured a significant $60.3M Series B financing round co-led by reputable investors, providing a strong financial foundation for growth and potential partnership opportunities.
Key Executive Appointments The addition of seasoned executives like Tracey Lodie as Chief Development Officer signifies strategic investments in leadership, potentially opening avenues for collaborations and business expansion.
Top Talent in Scientific Advisory Board By appointing distinguished experts like Nicole Paulk to the Scientific Advisory Board, GRO Biosciences demonstrates a commitment to pioneering research, presenting opportunities for scientific collaborations and innovation.
Experienced Board of Directors With the appointment of professionals like Rakhshita Dhar and Bruce Beutel to the Board of Directors, GRO Biosciences showcases a proficient leadership team, creating possibilities for strategic partnerships and industry recognition.
Industry Recognition and Growth Potential GRO Biosciences' focus on transforming protein therapeutics with new amino acid building blocks positions them alongside similar innovative companies, pointing towards potential synergies, shared market opportunities, and industry advancements.
Similar companies to GRO Biosciences
Notch Therapeutics
$10M$50MLygos
$10M$50MInsilico Medicine
$50M$100MAbsci
$10M$50MProteinQure
$10MArzeda
$10MC16 Biosciences
$10MCarlsmed
$10M$50M
GRO Biosciences Tech Stack
GRO Biosciences uses 8 technology products and services including WordPress, Cloudflare, Microsoft Word, and more. Explore GRO Biosciences's tech stack below.
- WordPressContent Management System
- CloudflareContent Management System
- Microsoft WordEditors
- Font AwesomeFont Scripts
- wpBakeryPage Builders
- PythonProgramming Languages
- Contact Form 7Web Platform Extensions
- MailChimp for WordPressWeb Platform Extensions
Media & News
GRO Biosciences's Email Address Formats
GRO Biosciences uses at least 1 format(s):
| GRO Biosciences Email Formats | Percentage |
| First.Last@grobio.com | 89% |
| FLast@grobio.com | 5% |
| Fir.Last@grobio.com | 3% |
| FirstLast@grobio.com | 3% |
Frequently Asked Questions
Where is GRO Biosciences's headquarters located?
GRO Biosciences's main headquarters is located at Pagliuca Harvard Life Lab 127 Western Ave. Boston, MA 02134 US. The company has employees across 2 continents, including North AmericaAsia. What is GRO Biosciences's official website and social media links?
GRO Biosciences's official website is grobio.com and has social profiles on LinkedIn.How much revenue does GRO Biosciences generate?
As of October 2024, GRO Biosciences's annual revenue reached $3.8M. What is GRO Biosciences's NAICS code?
GRO Biosciences's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.How many employees does GRO Biosciences have currently?
As of October 2024, GRO Biosciences has approximately 33 employees across 2 continents, including North AmericaAsia. Key team members include Chief Development Officer: T. L.Chief Business Officer: E. T. S.Chief Scientific Officer: C. J. G.. Explore GRO Biosciences's employee directory with LeadIQ.What industry does GRO Biosciences belong to?
GRO Biosciences operates in the Pharmaceutical Manufacturing industry. What technology does GRO Biosciences use?
GRO Biosciences's tech stack includes WordPressCloudflareMicrosoft WordFont AwesomewpBakeryPythonContact Form 7MailChimp for WordPress. What is GRO Biosciences's email format?
GRO Biosciences's email format typically follows the pattern of . Find more GRO Biosciences email formats with LeadIQ. How much funding has GRO Biosciences raised to date?
As of October 2024, GRO Biosciences has raised $60M in funding. The last funding round occurred on Jul 19, 2024 for $60M.When was GRO Biosciences founded?
GRO Biosciences was founded in 2016.
Company Overview
- Headquarters
- Pagliuca Harvard Life Lab 127 Western Ave. Boston, MA 02134 US
- Website
- grobio.com
- NAICS Code
- 3254 - Pharmaceutical and Medicine Manufacturing
- Founded
- 2016
- Employees
- 11-50
Media & News
Funding & Financials
- $60M
GRO Biosciences has raised a total of $60M of funding over 7 rounds. Their latest funding round was raised on Jul 19, 2024 in the amount of $60M.
- $10M
GRO Biosciences's revenue is in the range of $10M
Funding & Financials
- $60M
GRO Biosciences has raised a total of $60M of funding over 7 rounds. Their latest funding round was raised on Jul 19, 2024 in the amount of $60M.
- $10M
GRO Biosciences's revenue is in the range of $10M
Company Leadership
T. L.Chief Development Officer
E. T. S.Chief Business Officer
C. J. G.Chief Scientific Officer- E. T.Chief Business Officer Of Ribon Therapeutics
- E. S.Chief Business Officer
Employee Directory
- E. T.Chief Business Officer Of Ribon Therapeutics
- E. S.Chief Business Officer
- R. W.Associate Director / Team Lead, Biofoundry
- S. P.Associate Director And Cell Biology Team Lead
- B. B.Director, Program Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
